Literature DB >> 3087919

Changes in erythropoiesis due to radiation or chemotherapy as studied by flow cytometric determination of peripheral blood reticulocytes.

H J Tanke, P H van Vianen, F M Emiliani, I Neuteboom, N de Vogel, A D Tates, E A de Bruijn, A T van Oosterom.   

Abstract

Flow cytometric determination of time dependent changes of numbers of reticulocytes in peripheral blood were investigated as a parameter for changes in erythropoiesis induced by radiation- or chemotherapy. Rats irradiated or treated with drugs (such as e.g. cyclophosphamide 100 mg/kg, vincristin 0.2 mg/kg, or mitomycin C 1.0 mg/kg) showed clear changes in erythropoietic activity. Reticulocyte numbers decreased rapidly until day 3-4 after treatment; this period was followed by a gradual increase and normal control values were seen at day 8-11. Radiation effects of doses as low 0.5 Gy could be detected in such a way. Similar studies were performed with patients with ovarian tumors treated with cis-platinum, a drug that may cause non-immune haemolysis. During prolonged treatment some patients showed increasing numbers of reticulocytes, measured at the first day of each hospitalization period, whereas leucocyte and platelet counts stayed more or less constant. Increasing numbers of reticulocytes generally indicates stimulation of erythropoietic activity of the bone marrow (due to increased blood loss); in this study increasing numbers often preceeded a decrease in hemoglobin values later on. Flow cytometric analysis of reticulocytes is therefore a potentially useful tool to detect changes in erythropoiesis, and considered more sensitive for the early recognition of patients that develop anemia, than hemoglobin measurements only.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3087919     DOI: 10.1007/bf00482989

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  11 in total

1.  New methylene blue as a reticulocyte stain.

Authors:  G BRECHER
Journal:  Am J Clin Pathol       Date:  1949-09       Impact factor: 2.493

2.  Determination of the circulating red cell volume in man by radioactive chromium.

Authors:  K STERLING; S J GRAY
Journal:  J Clin Invest       Date:  1950-12       Impact factor: 14.808

Review 3.  Toxic effects of cis-dichlorodiammineplatinum(II) in man.

Authors:  D D Von Hoff; R Schilsky; C M Reichert; R L Reddick; M Rozencweig; R C Young; F M Muggia
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

Review 4.  Erythropoiesis: normal and abnormal.

Authors:  R S Hillman; C A Finch
Journal:  Semin Hematol       Date:  1967-10       Impact factor: 3.851

5.  Flow cytometry of human reticulocytes based on RNA fluorescence.

Authors:  H J Tanke; I A Nieuwenhuis; G J Koper; J C Slats; J S Ploem
Journal:  Cytometry       Date:  1981-03

6.  A rapid, vital staining procedure for flow cytometric analysis of human reticulocytes.

Authors:  B H Sage; J P O'Connell; T J Mercolino
Journal:  Cytometry       Date:  1983-11

7.  Cisplatin-induced hemolysis.

Authors:  E P Getaz; S Beckley; J Fitzpatrick; A Dozier
Journal:  N Engl J Med       Date:  1980-02-07       Impact factor: 91.245

8.  Preferential inhibition of the activity of a stimulatory protein of eukaryotic transcription by platinum (II) complexes.

Authors:  N Matsumoto; K Sekimizu; M Horikoshi; M Ohtsuki; Y Kidani; S Natori
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

9.  The effects of cisplatin on normal human erythrocytes in vitro.

Authors:  M Dawson; E A Brown; R D Barr
Journal:  Scand J Haematol       Date:  1983-09

10.  Flow cytometry of reticulocytes applied to clinical hematology.

Authors:  H J Tanke; P H Rothbarth; J M Vossen; G J Koper; J S Ploem
Journal:  Blood       Date:  1983-06       Impact factor: 22.113

View more
  3 in total

Review 1.  Reticulocytes and reticulocyte enumeration.

Authors:  R S Riley; J M Ben-Ezra; R Goel; A Tidwell
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  Reticulocyte maturity as an indicator for estimating qualitative abnormality of erythropoiesis.

Authors:  K Watanabe; Y Kawai; K Takeuchi; N Shimizu; H Iri; Y Ikeda; B Houwen
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

3.  Pharmacodynamic model for chemotherapy-induced anemia in rats.

Authors:  Sukyung Woo; Wojciech Krzyzanski; William J Jusko
Journal:  Cancer Chemother Pharmacol       Date:  2007-09-22       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.